CB21492-3 - 0x0000000000002F5D

Study Number: CB21492
Group Number: 3
Study Requirement: Healthy Normal Male and Female
Stipend: $8,900.00

Study Criteria:

  • Age: 18 - 55
  • BMI: 18 - 32
  • Weight Restriction: minimum weight 111 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Hepatits C.
  • Route of Administration: Oral
  • Blood Draws: 25

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 20 Night Stay & 6 Returns

Screening Dates:

Event Day Event Date Site
Wednesday 8/23/2017 Phoenix

Doctor Exam Dates:

Event Day Event Date Site
Wednesday 8/30/2017 Phoenix
Friday 9/1/2017 Phoenix

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 9/14/2017 10:00:00 AM 10/4/2017 9:00:00 AM 1 Phoenix
Return Sunday 10/8/2017 6:30:00 AM Sunday 10/8/2017 8:45:00 AM 3 Phoenix
Return Sunday 10/15/2017 6:30:00 AM Sunday 10/15/2017 5:45:00 PM 3 Phoenix
Return Sunday 10/22/2017 6:30:00 AM Sunday 10/22/2017 8:45:00 AM 3 Phoenix
Return Sunday 10/29/2017 6:30:00 AM Sunday 10/29/2017 8:45:00 AM 3 Phoenix
Return Sunday 11/5/2017 6:30:00 AM Sunday 11/5/2017 7:30:00 AM 3 Phoenix
Return Sunday 11/12/2017 6:30:00 AM Sunday 11/12/2017 8:45:00 AM 3 Phoenix